NQO1 and obesity disorder: β-Lap is known to have variety of pharmacological activities, including anticancer, antioxidant, antifungal, antibacterial, anti-inflammatory, anti-obesity, neuroprotective and nephroprotective properties, with low toxicity, mainly through the activation of NAD(P)H: quinone oxidoreductase 1 (NQO1) and the inhibition of topoisomerase I [1,2,3].